Skip to main content

previous disabled Page of 2
and
  1. No Access

    Reference Work Entry In depth

    Signal Transducers and Activators of Transcription in Oncogenesis

    Ralf Buettner, Roy Garcia, Richard Jove in Encyclopedia of Cancer (2017)

  2. Article

    Open Access

    Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer

    The EGFR signaling pathway is frequently activated in human ovarian cancer and associated with poor prognosis. However, inhibition of EGFR signaling in patients with recurrent ovarian cancer has been disappoin...

    Wei Wen, Jun Wu, Lucy Liu, Yan Tian, Ralf Buettner, Meng-Yin Hsieh in Molecular Cancer (2015)

  3. No Access

    Living Reference Work Entry In depth

    Signal Transducers and Activators of Transcription in Oncogenesis

    Ralf Buettner, Roy Garcia, Richard Jove in Encyclopedia of Cancer

  4. No Access

    Reference Work Entry In depth

    Signal Transducers and Activators of Transcription in Oncogenesis

    Ralf Buettner, Richard Jove, Roy Garcia in Encyclopedia of Cancer (2011)

  5. No Access

    Reference Work Entry In depth

    Signal Transducers and Activators of Transcription in Oncogenesis

    Ralf Buettner, Roy Garcia, Richard Jove in Encyclopedia of Cancer (2009)

  6. No Access

    Article

    Signal Transduction Proteins in Tumors From Puerto Rican and Caucasian Gastric Adenocarcinoma Patients: Expression Differences With Potential for Specific Targeted Therapies

    Overexpression of the HER2/NEU gene is associated with aggressive behavior and poor prognosis in breast cancer, making the Her2/neu protein a directed-therapy target. Tumors of two Puerto Rican (PR) patients over...

    José Cangiano, Barbara A. Centeno in Digestive Diseases and Sciences (2008)

  7. No Access

    Article

    Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways

    Vascular endothelial growth factor (VEGF) upregulation is induced by many receptor and intracellular oncogenic proteins commonly activated in cancer, rendering molecular targeting of VEGF expression a complex ...

    Qing Xu, Jon Briggs, Sungman Park, Guilian Niu, Marcin Kortylewski in Oncogene (2005)

  8. No Access

    Article

    Targeting STAT3 affects melanoma on multiple fronts

    As a point of convergence for numerous oncogenic signaling pathways, STAT3 is constitutively-activated at 50 to 90% frequency in diverse human cancers, including melanoma. A critical role of STAT3 in tumor cel...

    Marcin Kortylewski, Richard Jove, Hua Yu in Cancer and Metastasis Reviews (2005)

  9. No Access

    Article

    Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer

    Members of the signal transducers and activators of transcription (STAT) pathway have recently been demonstrated to have a major role in cancer. Constitutive activation of the STAT family members Stat3 and Sta...

    Eric B Haura, James Turkson, Richard Jove in Nature Clinical Practice Oncology (2005)

  10. No Access

    Article

    Stat3 regulates genes common to both wound healing and cancer

    Wound healing and cancer are both characterized by cell proliferation, remodeling of extracellular matrix, cell invasion and migration, new blood vessel formation, and modulation of blood coagulation. The mech...

    Daniel J Dauer, Bernadette Ferraro, Lanxi Song, Bin Yu, Linda Mora in Oncogene (2005)

  11. No Access

    Article

    Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity

    Constitutive activation of the JAK/STAT3 pathway is a major contributor to oncogenesis. In the present study, structure–activity relationship (SAR) studies with five cucurbitacin (Cuc) analogs, A, B, E, I, and...

    Jiazhi Sun, Michelle A Blaskovich, Richard Jove, Sandra K Livingston in Oncogene (2005)

  12. No Access

    Article

    Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells

    Stat3 (signal transducer and activator of transcription-3) activity is required for transformation by a number of oncogenes, while a constitutively active form of Stat3 alone is sufficient to induce neoplastic...

    Adina Vultur, Jun Cao, Rozanne Arulanandam, James Turkson, Richard Jove in Oncogene (2004)

  13. No Access

    Article

    Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells

    Overexpression of receptor tyrosine kinases including the epidermal growth factor receptor (EGF-R) as well as nonreceptor tyrosine kinases, such as Src, have been implicated in the formation of human lung canc...

    Lanxi Song, James Turkson, James G Karras, Richard Jove, Eric B Haura in Oncogene (2003)

  14. No Access

    Article

    Inhibition of Bcr–Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells

    Chronic myelogenous leukemia (CML) is a myeloproliferative disease characterized by the BCR–ABL genetic translocation and constitutive activation of the Abl tyrosine kinase. Among members of the Signal Transdu...

    Mei Huang, Jay F Dorsey, PK Epling-Burnette, Ramadevi Nimmanapalli in Oncogene (2002)

  15. No Access

    Article

    Roles of activated Src and Stat3 signaling in melanoma tumor cell growth

    Activation of protein tyrosine kinases is prevalent in human cancers and previous studies have demonstrated that Stat3 signaling is a point of convergence for many of these tyrosine kinases. Moreover, a critic...

    Guilian Niu, Tammy Bowman, Mei Huang, Steve Shivers, Douglas Reintgen in Oncogene (2002)

  16. No Access

    Article

    Identification of Src transformation fingerprint in human colon cancer

    We used a classical rodent model of transformation to understand the transcriptional processes, and hence the molecular and cellular events a given cell undergoes when progressing from a normal to a transforme...

    Renae L Malek, Rosalyn B Irby, Qingbin M Guo, Kerry Lee, Sylvia Wong, Mei He in Oncogene (2002)

  17. No Access

    Article

    MEKK1-induced apoptosis requires TRAIL death receptor activation and is inhibited by AKT/PKB through inhibition of MEKK1 cleavage

    MEK kinase 1 (MEKK1) induces apoptosis through the activation of caspases. The mechanism for MEKK1-induced apoptosis involves caspase-mediated cleavage of MEKK1, releasing a pro-apoptotic 91 kDa kinase fragmen...

    Andrea H Bild, Francisco J Mendoza, Erika M Gibson, Mei Huang in Oncogene (2002)

  18. No Access

    Article

    Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis

    Non-receptor and receptor tyrosine kinases, such as Src and EGF receptor (EGFR), are major inducers of vascular endothelial growth factor (VEGF), one of the most potent mediators of angiogenesis. While tyrosin...

    Guilian Niu, Kenneth L Wright, Mei Huang, Lanxi Song, Eric Haura, James Turkson in Oncogene (2002)

  19. No Access

    Article

    Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis

    Hepatocyte Growth Factor/Scatter Factor (HGF/SF) mediates a wide variety of cellular responses by acting through the Met tyrosine kinase receptor. Inappropriate expression of HGF/SF and/or Met has been found i...

    Yu-Wen Zhang, Ling-Mei Wang, Richard Jove, George F Vande Woude in Oncogene (2002)

  20. No Access

    Article

    Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

    Constitutive activation of signal transducer and activator of transcription (STAT) proteins has been detected in a wide variety of human primary tumor specimens and tumor cell lines including blood malignancie...

    Roy Garcia, Tammy L Bowman, Guilian Niu, Hua Yu, Sue Minton in Oncogene (2001)

previous disabled Page of 2